Gland Pharma Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹1490 - ₹1500
- Lot size
- 10 shares
- Issue amount
- ₹6,479.55 cr
- Total subscription
- 0×
- Opens
- 9 Nov 2020
- Closes
- 11 Nov 2020
- Allotment
- 18 Nov 2020
- Listing
- 20 Nov 2020
Offer at a glance
Issue overview
- Issue size
- 4,31,96,968 shares
- Face value
- ₹1 per share
- Minimum investment
- ₹14,900
- Fresh issue
- ₹1,250 cr
- Offer for sale
- ₹5,229.55 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹15,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 15,49,49,490
- Shares after issue
- 16,32,82,823
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 10 | ₹15,000 |
| sHNI | 14 | 140 | ₹2,10,000 |
| bHNI | 67 | 670 | ₹10,05,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.
Strengths
- Wide range of complex injectable products.
- Diversified B2B model with a growing B2C presence in India.
- Advanced and scalable manufacturing capabilities.
- Strong financial performance and consistent growth.
- Led by an experienced and skilled management team.
Promoters
Fosun Pharma Industrial Pte. Ltd
Shanghai Fosun Pharmaceutical (Group) Co. Ltd
Registrar & documents
Lead manager
Citigroup Global Markets India Private Limited, Haitong Securities India Private Limited, Kotak Mahindra Capital Company Limited, Nomura Financial Advisory And Securities (India) Private Limited, Securities (India) Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Sy. No. 143 - 148, 150 and 151, Near Gandi Maisamma 'X' Roads, D.P. Pally,Dundigal Medchal-Malkajgiri District, Hyderabad
+91 40 3051 0999
[email protected]Company website ↗Understanding GLAND IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.